secwatch / observer
8-K filed October 7, 2025, 7:59 PM ET ticker PETS CIK 0001040130
other material confidence high sentiment negative materiality 0.85

PETMED EXPRESS INC (PETS): auditor change — PetMed Express to restate FY2024, FY2023; investigation reveals revenue errors, former CEO/CFO out

PETMED EXPRESS INC

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

PETMED EXPRESS INC reported that prior financial statements should not be relied upon.

Action
non reliance
Auditor
RSM US LLP
Exact text from the filing
The Audit Committee’s conclusion that the Affected Financials should no longer be relied upon
View on SEC.gov
Restructurings & Charges SEC 8-K Item 2.05/2.06 confidence 0.9

PETMED EXPRESS INC announced a impairment with charges of $1.2 million affecting PCRX trade name.

Type
impairment
Charge
$1.2 million
Affected area
PCRX trade name
Exact text from the filing
On October 1, 2025, the Audit Committee of the Board of Directors (the “Audit Committee”) of PetMed Express, Inc. (the “Company”), upon the recommendation of the Company’s management, concluded that a $1.2 million non-cash impairment of the Company’s PCRX trade name is required to be recorded in the quarter ended March 31, 2025.
View on SEC.gov

15 auditor changes filed in the last 30 days. Browse all auditor changes →

PETMED EXPRESS INC filing history →

Source: SEC EDGAR
accession 0001040130-25-000064
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.